Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check13 days agoChange DetectedThe study record history now includes a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study record history shows Vojtech Melenovsky, MD, PhD listed as the responsible party, adds 'Last verified' and 'Last known status' details, and records a new Revision: v3.6.0; older entries including 'Last known status was:', 'Verified', and Revision: v3.5.5 are removed.SummaryDifference3%

- Check34 days agoChange DetectedA new revision entry v3.5.5 is now shown in the study record's history, replacing the previous v3.5.4. This indicates an update to the record's metadata.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now presents the study header and provenance details along with a version-history section, including the study title, sponsor, investigator, and dates for study record versions.SummaryDifference10%

- Check48 days agoChange DetectedThe page version removes several history and export options, reducing the UI elements shown for version history and related actions.SummaryDifference7%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.